查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1507224

ADHD市场、占有率、规模、趋势、行业分析报告：依药物类型、通路、人口统计、地区、细分市场预测，2024-2032年

Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, Non-Stimulants); By Distribution Channel; By Demographics; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球ADHD市场规模将达到305.6894亿美元。本研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

ADHD盛行率的上升直接刺激了对诊断服务、治疗介入和持续管理解决方案的需求，显着推动了市场发展。医疗保健专业人员和公众对ADHD症状和对生活品质影响的认识不断提高，导致诊断更加频繁和更早。因此，药物和行为治疗（包括兴奋剂和非兴奋剂药物）的市场日益扩大。

此外，认识到ADHD是一种需要长期管理的慢性疾病，将进一步推动市场成长，并鼓励继续研究和开发新的和增强的治疗方案。人们越来越认识到ADHD在儿童和成人中都普遍存在，这日益扩大市场，并增加对针对不同年龄层和个人需求的各种治疗的需求。

ADHD市场受到多种因素的影响，包括患病率上升、医生和患者意识的提高以及诊断和治疗方法的进步。然而，诊断不足、严格的监管流程和高昂的药品成本等挑战可能会阻碍未来的市场成长。市场竞争激烈，几家主要製药公司透过大力投资研发和广泛的产品来引领市场。这些公司致力于创造新的和增强的药物，包括兴奋剂和非兴奋剂药物选择，以满足ADHD患者的多样化需求。

ADHD市场报告要点

由于其在治疗ADHD症状方面的既定功效和快速起效，兴奋剂类别占据了最大的市场占有率。

随着对ADHD的认识和诊断不断提高，医院药房行业预计在未来几年将出现显着成长。这一趋势导致越来越多的患者寻求专门护理和综合管理计划，这些计划通常由医院提供。

到2023年，北美将因其 ADHD 的高诊断率而主导市场。这是由于该地区的医疗保健提供者和普通民众对这种疾病的认识和认识不断提高。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球 ADHD 市场洞察

  • ADHD行业概况
  • ADHD市场动态
    • 推动因素和机会
      • ADHD盛行率不断上升
      • 轻鬆获得行为復健治疗
    • 抑制因素和挑战
      • 缺乏足够的补偿
  • PESTEL 分析
  • ADHD市场的产业趋势
  • 价值链分析
  • 新冠肺炎（COVID-19）影响分析

第5章 全球ADHD市场：依药物类型

  • 主要发现
  • 简介
  • 精神兴奋剂
  • 非精神兴奋剂

第6章 全球 ADHD 市场：依通路

  • 主要发现
  • 简介
  • 零售药局
  • 医院药房

第7章 全球ADHD市场：依人口统计

  • 主要发现
  • 简介
  • 儿童（2 至 17 岁）
  • 成人

第8章 全球ADHD市场：依地区

  • 主要发现
  • 简介
    • ADHD市场评估：依地区，2019-2032年
  • 北美
    • 北美：依药物类型，2019-2032年
    • 北美：人口统计资料，2019-2032年
    • 北美：依通路，2019-2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依药物类型，2019-2032年
    • 欧洲：人口统计资料，2019-2032年
    • 欧洲：依通路，2019-2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依药物类型，2019-2032年
    • 亚太地区：依人口统计资料，2019-2032年
    • 亚太地区：依通路，2019-2032年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
  • 中东、非洲
    • 中东和非洲：依药物类型，2019-2032年
    • 中东和非洲：按人口统计资料，2019-2032年
    • 中东与非洲：依通路，2019-2032年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依药物类型，2019-2032年
    • 拉丁美洲：人口统计资料，2019-2032年
    • 拉丁美洲：依通路，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 竞争态势

  • 扩张与收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章 公司简介

  • ADVANZ PHARMA
  • Amneal Pharmaceuticals LLC
  • Aytu Biopharma, Inc
  • Eli Lilly and Company
  • Johnson & Johnson Services, Inc
  • Lupin
  • Mallinckrodt
  • Novartis AG
  • Noven Pharmaceuticals, Inc
  • Sun Pharmaceutical Industries Ltd
  • Supernus Pharmaceuticals, Inc
  • Takeda Pharmaceutical Company Limited
  • Torrent Pharmaceuticals Ltd
  • Tris Pharma, Inc
  • Zevra Therapeutics
Product Code: PM2960

The global Attention Deficit Hyperactivity Disorder market size is expected to reach USD 30,568.94 Million by 2032, according to a new study by Polaris Market Research. The report "Attention Deficit Hyperactivity Disorder Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Stimulants, Non-Stimulants); By Distribution Channel; By Demographics; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The escalating prevalence of Attention Deficit Hyperactivity Disorder significantly propels the market, directly stimulating the demand for diagnostic services, therapeutic interventions, and ongoing management solutions. Heightened awareness among healthcare professionals and the general public regarding ADHD symptoms and their impact on quality of life has led to more frequent and earlier diagnoses. Consequently, this has expanded the market for both pharmaceutical treatments, including stimulants and non-stimulants, and behavioral therapies.

Furthermore, the acknowledgment of ADHD as a chronic condition necessitating long-term management further drives market growth, fostering ongoing research and development of novel and enhanced treatment options. The expanding recognition of ADHD's prevalence among both children and adults broadens the market scope, fueling demand for diverse treatment modalities tailored to different age groups and individual needs.

A number of factors impact the ADHD market, including the rising prevalence of the disorder, increased awareness among physicians and patients, and advancements in diagnostic and treatment methods. However, challenges such as underdiagnosis, rigorous regulatory processes, and high medication costs may impede market growth in the future. The market is highly competitive, with several major pharmaceutical companies leading the way through significant investment in research and development and a wide range of products. These companies are dedicated to creating new and enhanced medications, including stimulant and non-stimulant options, to cater to the varied requirements of patients with ADHD.

Attention Deficit Hyperactivity Disorder Market Report Highlights

The stimulant drug category held the largest market share due to its established effectiveness and quick onset of action in the management of ADHD symptoms.

The hospital pharmacy sector is expected to experience significant growth in the coming years as awareness and diagnosis of ADHD continue to rise. This trend is leading to an increase in the number of patients seeking specialized care and comprehensive management plans, which are typically offered in hospital settings.

In 2023, North America dominated the market due to the high incidence of ADHD diagnoses. This can be attributed to increased awareness and acknowledgment of the disorder among healthcare providers and the general population in the region.

The global key market players include ADVANZ PHARMA, Amneal Pharmaceuticals LLC, Aytu BioPharma, Inc, Eli Lilly and Company, Johnson & Johnson Services, Inc, Lupin, Mallinckrodt, Novartis AG, Noven Pharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Supernus Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, Torrent Pharmaceuticals Ltd, Tris Pharma, Inc, Zevra Therapeutics, etc.

Polaris Market Research has segmented the artificial lift market report based on drug type, distribution channel, demographics, and region:

Attention Deficit Hyperactivity Disorder, Drug Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Stimulants
  • Non-Stimulants

Attention Deficit Hyperactivity Disorder, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Retail Pharmacy
  • Hospital Pharmacy

Attention Deficit Hyperactivity Disorder, Demographics Outlook (Revenue - USD Million, 2019 - 2032)

  • Children (2 to 17 years of age)
  • Adults

Attention Deficit Hyperactivity Disorder, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Austria
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Attention Deficit Hyperactivity Disorder Market Insights

  • 4.1. Attention Deficit Hyperactivity Disorder - Industry Snapshot
  • 4.2. Attention Deficit Hyperactivity Disorder Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Attention Deficit Hyperactivity Disorder
      • 4.2.1.2. Easy Availability of Behavioural Rehabilitation Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of Proper Reimbursement
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Attention Deficit Hyperactivity Disorder Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • 5.3. Stimulants
    • 5.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Stimulants, by Region, 2019-2032 (USD Million)
  • 5.4. Non-stimulants
    • 5.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Non-stimulants, by Region, 2019-2032 (USD Million)

6. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Retail Pharmacy, by Region, 2019-2032 (USD Million)
  • 6.4. Hospital Pharmacy
    • 6.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Million)

7. Global Attention Deficit Hyperactivity Disorder Market, by Demographics

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • 7.3. Children (2 to 17 years of age)
    • 7.3.1. Global Attention Deficit Hyperactivity Disorder Market, by Children (2 to 17 years of age), by Region, 2019-2032 (USD Million)
  • 7.4. Adults
    • 7.4.1. Global Attention Deficit Hyperactivity Disorder Market, by Adults, by Region, 2019-2032 (USD Million)

8. Global Attention Deficit Hyperactivity Disorder Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Attention Deficit Hyperactivity Disorder Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Attention Deficit Hyperactivity Disorder Market - North America
    • 8.3.1. North America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.3.3. North America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.4. Attention Deficit Hyperactivity Disorder Market - U.S.
      • 8.3.4.1. U.S.: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.5. Attention Deficit Hyperactivity Disorder Market - Canada
      • 8.3.5.1. Canada: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.4. Attention Deficit Hyperactivity Disorder Market - Europe
    • 8.4.1. Europe: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.4.3. Europe: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.4. Attention Deficit Hyperactivity Disorder Market - UK
      • 8.4.4.1. UK: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.5. Attention Deficit Hyperactivity Disorder Market - France
      • 8.4.5.1. France: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.5.3. France: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.6. Attention Deficit Hyperactivity Disorder Market - Germany
      • 8.4.6.1. Germany: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.7. Attention Deficit Hyperactivity Disorder Market - Italy
      • 8.4.7.1. Italy: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.8. Attention Deficit Hyperactivity Disorder Market - Spain
      • 8.4.8.1. Spain: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.9. Attention Deficit Hyperactivity Disorder Market - Netherlands
      • 8.4.9.1. Netherlands: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.10. Attention Deficit Hyperactivity Disorder Market - Russia
      • 8.4.10.1. Russia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.5. Attention Deficit Hyperactivity Disorder Market - Asia Pacific
    • 8.5.1. Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.4. Attention Deficit Hyperactivity Disorder Market - China
      • 8.5.4.1. China: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.4.3. China: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.5. Attention Deficit Hyperactivity Disorder Market - India
      • 8.5.5.1. India: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.5.3. India: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.6. Attention Deficit Hyperactivity Disorder Market - Malaysia
      • 8.5.6.1. Malaysia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.7. Attention Deficit Hyperactivity Disorder Market - Japan
      • 8.5.7.1. Japan: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.8. Attention Deficit Hyperactivity Disorder Market - Indonesia
      • 8.5.8.1. Indonesia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.9. Attention Deficit Hyperactivity Disorder Market - South Korea
      • 8.5.9.1. South Korea: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.6. Attention Deficit Hyperactivity Disorder Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.4. Attention Deficit Hyperactivity Disorder Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.5. Attention Deficit Hyperactivity Disorder Market - UAE
      • 8.6.5.1. UAE: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.6. Attention Deficit Hyperactivity Disorder Market - Israel
      • 8.6.6.1. Israel: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.7. Attention Deficit Hyperactivity Disorder Market - South Africa
      • 8.6.7.1. South Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • 8.7. Attention Deficit Hyperactivity Disorder Market - Latin America
    • 8.7.1. Latin America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.4. Attention Deficit Hyperactivity Disorder Market - Mexico
      • 8.7.4.1. Mexico: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.5. Attention Deficit Hyperactivity Disorder Market - Brazil
      • 8.7.5.1. Brazil: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.6. Attention Deficit Hyperactivity Disorder Market - Argentina
      • 8.7.6.1. Argentina: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. ADVANZ PHARMA
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amneal Pharmaceuticals LLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Aytu Biopharma, Inc
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eli Lilly and Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Johnson & Johnson Services, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Lupin
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mallinckrodt
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Noven Pharmaceuticals, Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sun Pharmaceutical Industries Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Supernus Pharmaceuticals, Inc
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Takeda Pharmaceutical Company Limited
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Torrent Pharmaceuticals Ltd
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Tris Pharma, Inc
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zevra Therapeutics
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 2 Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 3 Global Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 4 Attention Deficit Hyperactivity Disorder Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 6 North America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 7 North America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 8 U.S.: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 10 U.S.: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 11 Canada: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 12 Canada: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 13 Canada: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 14 Europe: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 15 Europe: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 16 Europe: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 17 UK: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 18 UK: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 19 UK: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 20 France: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 21 France: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 22 France: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 23 Germany: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 24 Germany: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 25 Germany: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 26 Italy: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 27 Italy: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 28 Italy: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 29 Spain: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 30 Spain: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 31 Spain: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 32 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 34 Netherlands: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 35 Russia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 36 Russia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 37 Russia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 41 China: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 42 China: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 43 China: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 44 India: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 45 India: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 46 India: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 47 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 49 Malaysia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 50 Japan: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 51 Japan: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 52 Japan: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 53 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 55 Indonesia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 56 South Korea: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 58 South Korea: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 65 UAE: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 66 UAE: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 67 UAE: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 68 Israel: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 69 Israel: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 70 Israel: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 71 South Africa: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 73 South Africa: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 74 Latin America: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 76 Latin America: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 77 Mexico: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 79 Mexico: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 80 Brazil: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 82 Brazil: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)
  • Table 83 Argentina: Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 85 Argentina: Attention Deficit Hyperactivity Disorder Market, by Demographics, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Attention Deficit Hyperactivity Disorder Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel, 2021 & 2030 (USD Million)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Attention Deficit Hyperactivity Disorder Market, by Drug Type, 2021 & 2030 (USD Million)
  • Figure 10. Market by Demographics
  • Figure 11. Global Attention Deficit Hyperacti